List of articles in "Drug" category - Page 482

Triamterene (trade name Dyrenium) is a potassium-sparing diuretic used in combination with thiazide diuretics for the treatment of hypertension and edema. In combination with hydrochlorothiazide it is marketed under the […]

Terfenadine was an antihistamine formerly used for the treatment of allergic conditions. It was brought to market by Hoechst Marion Roussel (now Sanofi-Aventis) and marketed under various brand names including […]

Primidone is an anticonvulsant of the pyrimidinedione class the active metabolites of which phenobarbital (minor) and phenylethylmalonamide (PEMA) (major) are also anticonvulsants. It is used mainly to treat complex partial […]

Prontosil the first commercially available antibacterial drug was developed in the 1930s by a research team at the Bayer Laboratories of the IG Farben conglomerate in Germany. It has a […]

Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the […]

Zimelidine (Zimeldine Normud Zelmid) was the first selective serotonin reuptake inhibitor (SSRI) antidepressant to be marketed. It is a pyridylallylamine and is structurally different from other antidepressants. Zimelidine was developed […]

Pentoxifylline (INN BAN USAN) or oxpentifylline (AAN) is a drug commonly sold by Sanofi under the brand name Trental. Its chemical name is 1-(5-oxohexyl)-3 7-dimethylxanthine. Pentoxifylline is a xanthine derivative. […]

Loracarbef is an antibiotic. Its use was discontinued in 2006.[citation needed] It is a carbacephem but it is sometimes grouped together with the second-generation cephalosporin antibiotics. It was marketed under […]

Dutasteride (trademark name Avodart manufactured by GlaxoSmithKline) is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT). Used for benign prostatic hyperplasia; however it increases the […]

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) approved by the U.S. Food and Drug Administration in January 1991.